While non-steroidal MRAs have not yet been investigated in type 1 diabetes, based on their observed benefits in type 2 diabetes and their mechanism of action, similar kidney-protective effects are anticipated, emphasising the need for dedicated studies with finerenone in people with type 1 diabetes and CKD, including their use in combination with other repurposed therapies such as SGLT2i and GLP1-RAs
Receive support Ongoing Support
Also referred to as the mother of all antioxidants, this brings with it both benefits and side effects
Made by Novo Nordisk, Ozempic is one of several GLP-1 agonists well known for its weight-loss benefits
In the sermorelin vs CJC-1295 vs ipamorelin comparison, sermorelin and CJC-1295 are both GHRH analogues that activate the GHRH receptor on pituitary cells they differ primarily in half-life (sermorelin: 10-20 minutes, CJC-1295 no DAC: ~30 minutes, CJC-1295 with DAC: 6-8 days)
Toxoplasma gondii and schizophrenia: linkage through astrocyte-derived kynurenic acid
